Ovarian Cancer and Immune Response to Flu Vaccine
Conditions
Ovarian Cancer
Conditions: official terms
Ovarian Neoplasms
Conditions: Keywords
Advanced Ovarian and Primary Peritoneal Cancer in Remission
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Intervention
Name: The current season's trivalent killed influenza vaccine
Type: Biological
Overall Status
Recruiting
Summary
The purpose of this study is to determine what the immune response is of ovarian cancer patients in remission, when they are given the flu vaccine. After receiving the flu vaccine, patients will have blood drawn 5 times in 12 months to study antibody response to the flu vaccine.
Criteria for eligibility
Healthy Volunteers:
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- All subjects must have a histologic diagnosis of epithelial ovarian cancer or primary peritoneal carcinoma. Time from completion of chemotherapy will be no more than 6 months.

- If no clinical evidence of disease is present after diagnosis with Stage III or IV disease and completion of primary surgery and chemotherapy, or, if no clinical evidence of disease is present after completion of chemotherapy for a disease recurrence diagnosed after a progression-free interval of at least 2 years, for patients of any initial stage.

Exclusion Criteria:

- Prior malignancy (except basal cell or squamous cell skin cancer) within the past five years.

- Presence of active CNS disease.

- Active bacterial, viral or fungal infections.

- Chemotherapy, biologic therapy, or radiation therapy < 4 weeks prior to study entry.

- History of active autoimmunity or immunosuppression.

- Use of immunosuppressive drugs within 4 weeks prior to study entry. Patients may receive chemotherapy or other immunosuppressive medications at the discretion of their physician during the subsequent year after influenza vaccination without exclusion from the study.

- Patients with tumors of low malignant potential (borderline tumors) will not be eligible.

- Prior influenza vaccination with the current vaccine.

- History of serious sensitivity to eggs, or previous influenza vaccine.

- Pregnant of breastfeeding subjects.
Location
Department of Obstetrics and Gynecology, Division of GYN Oncology, Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Status: Recruiting
Sponsors
University of Pennsylvania
Source
University of Pennsylvania
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page